文献速递青光眼

ATP敏感性钾通道开放剂对高眼压动物模型眼压的影响

Effect of ATP-sensitive Potassium Channel Openers on Intraocular Pressure in Ocular Hypertensive Animal Models.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2022-01-01

研究评估ATP敏感性钾通道开放剂CKLP1和diazoxide在三种独立小鼠高眼压模型中对眼压的影响。CKLP1在TGFβ2过表达、类固醇诱导和DBA/2J模型中分别降低眼压20%、24%和43%;diazoxide在类固醇诱导和DBA/2J模型中降低眼压32%和41%。房水动力学分析显示药物通过降低巩膜外静脉压发挥作用,组织学和细胞形态正常。

要点

  • CKLP1降低TGFβ2过表达、类固醇诱导和DBA/2J小鼠眼压20%、24%和43%。
  • Diazoxide降低类固醇诱导和DBA/2J小鼠眼压32%和41%。
  • 药物通过降低巩膜外静脉压发挥作用,组织形态正常。

核心结论

  • ATP敏感性钾通道开放剂CKLP1和diazoxide通过降低巩膜外静脉压有效降低高眼压动物模型眼压,支持其在高眼压和青光眼中的潜在治疗应用。

研究设计与样本

  • 在TGFβ2过表达、类固醇诱导和虹膜色素分散(DBA/2J)三种独立小鼠高眼压模型中测量基线眼压,随后每日一次滴眼给予CKLP1(5 mM)或diazoxide(5 mM),用手持回弹式眼压计在清醒动物中测量眼压,并通过恒流灌注法评估房水动力学,用透射电镜评估眼组织。

主要发现

  • CKLP1使TGFβ2过表达小鼠眼压降低20%(n=6;P<0.0001),类固醇诱导高眼压小鼠降低24%(n=8;P<0.0001),DBA/2J小鼠降低43%(n=15;P<0.0001)。
  • Diazoxide使类固醇诱导高眼压小鼠眼压降低32%(n=13;P<0.0001),DBA/2J小鼠降低41%(n=4;P=0.005)。
  • CKLP1使TGFβ2过表达小鼠巩膜外静脉压降低29%(n=13;P<0.0001),DBA/2J小鼠降低72%(对照组n=4,治疗组n=3;P=0.0002)。
  • Diazoxide使类固醇诱导高眼压小鼠巩膜外静脉压降低35%(n=3;P=0.03)。
  • 组织学和细胞形态与对照组相比表现正常,在类固醇诱导高眼压模型中CKLP1和diazoxide治疗眼细胞外基质积累减少。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the effect of ATP-sensitive potassium channel openers cromakalim prodrug 1 (CKLP1) and diazoxide on IOP in three independent mouse models of ocular hypertension. METHODS: Baseline IOP was measured in TGFβ2 overexpression, steroid-induced, and iris dispersion (DBA/2J) ocular hypertension mouse models, followed by once daily eyedrop administration with CKLP1 (5 mM) or diazoxide (5 mM). The IOP was measured in conscious animals with a handheld rebound tonometer. Aqueous humor dynamics were assessed by a constant perfusion method. Effect of treatment on ocular tissues was evaluated by transmission electron microscopy. RESULTS: CKLP1 decreased the IOP by 20% in TGFβ2 overexpressing mice (n = 6; P < 0.0001), 24% in steroid-induced ocular hypertensive mice (n = 8; P < 0.0001), and 43% in DBA/2J mice (n = 15; P < 0.0001). Diazoxide decreased the IOP by 32% in mice with steroid-induced ocular hypertension (n = 13; P < 0.0001) and by 41% in DBA/2J mice (n = 4; P = 0.005). An analysis of the aqueous humor dynamics revealed that CKLP1 decreased the episcleral venous pressure by 29% in TGFβ2 overexpressing mice (n = 13; P < 0.0001) and by 72% in DBA/2J mice (n = 4 control, 3 treated; P = 0.0002). Diazoxide lowered episcleral venous pressure by 35% in steroid-induced ocular hypertensive mice (n = 3; P = 0.03). Tissue histology and cell morphology appeared normal when compared with controls. Accumulation of extracellular matrix was reduced in CKLP1- and diazoxide-treated eyes in the steroid-induced ocular hypertension model. CONCLUSIONS: ATP-sensitive potassium channel openers CKLP1 and diazoxide effectively decreased the IOP in ocular hypertensive animal models by decreasing the episcleral venous pressure, supporting a potential therapeutic application of these agents in ocular hypertension and glaucoma.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Roy Chowdhury U, Millar JC, Holman BH, et al. Effect of ATP-sensitive Potassium Channel Openers on Intraocular Pressure in Ocular Hypertensive Animal Models. Invest Ophthalmol Vis Sci. 2022. PMID: 35129587. doi:10.1167/iovs.63.2.15

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。